Valuation: Alembic Pharmaceuticals Limited

Market Cap 20TCr 220.96Cr 201.25Cr 185.44Cr 168.69Cr 316.46Cr 332.59Cr 2.26TCr 897.05Cr 11TCr 829.05Cr 811.58Cr 35TCr P/E 2027 *
22.9x
P/E 2028 * 19.5x
Enterprise Value 21TCr 230.93Cr 210.33Cr 193.81Cr 176.29Cr 330.73Cr 347.59Cr 2.36TCr 937.5Cr 12TCr 866.44Cr 848.18Cr 37TCr EV / Sales 2027 *
2.36x
EV / Sales 2028 * 2.18x
Free-Float
29.3%
Yield 2027 *
1.34%
Yield 2028 * 1.51%
1 day-0.82%
1 week+1.05%
Current month+30.47%
1 month+31.71%
3 months+27.87%
6 months+38.36%
Current year+23.02%
1 week 1,033.5
Extreme 1033.5
1,075
1 month 748.25
Extreme 748.25
1,075
Current year 635.8
Extreme 635.8
1,075
1 year 635.8
Extreme 635.8
1,075
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Chief Executive Officer 48 31/03/2026
Chief Executive Officer 51 31/03/2026
Director of Finance/CFO - 07/07/2025
Director TitleAgeSince
Chairman 78 08/06/2012
Director/Board Member 51 01/01/2007
Director/Board Member 66 18/01/2003
Date Insider Type Main position Quantity % Market Cap. Importance
28/03/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
24/03/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
21/03/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%+1.05%+15.73%+38.93% 220.96Cr
-0.30%-6.68%+29.12%+125.42% 1,20000Cr
+1.25%-5.35%+33.19%+80.42% 65TCr
+0.94%-2.99%+24.73%+106.93% 51TCr
-0.60%-1.95%+27.26%+67.32% 38TCr
+0.69%-9.50%+40.80%+30.23% 33TCr
+0.41%-4.70%+27.23%+51.59% 29TCr
+0.81%-4.08%-1.74%+32.71% 27TCr
-0.15%-6.45%+29.63%+64.18% 24TCr
-0.06%-0.98%+33.15%+118.99% 21TCr
Average +0.25%-4.17%+25.91%+71.67% 41TCr
Weighted average by Cap. +0.40%-5.19%+28.03%+87.47%

Financials

2027 *2028 *
Net sales 9.07TCr 98Cr 89Cr 82Cr 75Cr 140.22Cr 147.37Cr 1TCr 397.46Cr 4.95TCr 367.34Cr 359.59Cr 16TCr 9.7TCr 104.8Cr 95Cr 88Cr 80Cr 150.09Cr 157.74Cr 1.07TCr 425.45Cr 5.3TCr 393.2Cr 384.91Cr 17TCr
Net income 886.03Cr 9.57Cr 8.71Cr 8.03Cr 7.3Cr 14Cr 14Cr 98Cr 39Cr 483.95Cr 36Cr 35Cr 1.52TCr 1.04TCr 11Cr 10Cr 9.41Cr 8.56Cr 16Cr 17Cr 114.59Cr 46Cr 567.39Cr 42Cr 41Cr 1.78TCr
Net Debt 922.72Cr 9.96Cr 9.08Cr 8.36Cr 7.61Cr 14Cr 15Cr 101.78Cr 40Cr 503.99Cr 37Cr 37Cr 1.58TCr 647.39Cr 6.99Cr 6.37Cr 5.87Cr 5.34Cr 10Cr 11Cr 71Cr 28Cr 353.6Cr 26Cr 26Cr 1.11TCr
Projected Income Statement - Annual - Alembic Pharmaceuticals Limited
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
20/26/20 ₹1,040.95 -0.82% 1,91,247
19/26/19 ₹1,049.60 +0.50% 3,33,407
18/26/18 ₹1,044.35 -0.60% 2,28,735
17/26/17 ₹1,050.65 -0.61% 2,01,850
16/26/16 ₹1,057.10 +2.62% 4,52,099
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Alembic Pharmaceuticals Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,040.95INR
Average target price
1,075.90INR
Spread / Average Target
+3.36%
  1. Stock Market
  2. Stocks
  3. APLLTD Stock